NEW DRUG APPROVAL PROCESS
\njˈuː dɹˈʌɡ ɐpɹˈuːvə͡l pɹˈə͡ʊsɛs], \njˈuː dɹˈʌɡ ɐpɹˈuːvəl pɹˈəʊsɛs], \n_j_ˈuː d_ɹ_ˈʌ_ɡ ɐ_p_ɹ_ˈuː_v_əl p_ɹ_ˈəʊ_s_ɛ_s]\
Sort: Oldest first
-
Process that is gone through in order for a drug to receive approval by a government regulatory agency. This includes any required pre-clinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance of the drug.
By DataStellar Co., Ltd
